Human equilibrative nucleoside transporter 1 (hENT1) in gemcitabine and FOLFOX (oxaliplatin, 5-fluorouracil, and leucovorin)-treated patients with metastatic pancreatic cancer: The randomized phase II PAN1 study.
Yu Jo Chua
No relevant relationships to disclose
Christos Stelios Karapetis
No relevant relationships to disclose
Val Gebski
No relevant relationships to disclose
Rachel O'Connell
No relevant relationships to disclose
Stephen Begbie
No relevant relationships to disclose
Louise M. Nott
Honoraria - Roche; Sanofi
Michelle F. Cronk
No relevant relationships to disclose
Craig Underhill
No relevant relationships to disclose
Ehtesham A. Abdi
No relevant relationships to disclose
Thomas Van Hagen
No relevant relationships to disclose
Nicole Wong
No relevant relationships to disclose
Merryn Hall
No relevant relationships to disclose
Danielle Angela Ferraro
No relevant relationships to disclose
Katrin Marie Sjoquist
No relevant relationships to disclose
Cheryl Santos
No relevant relationships to disclose
John Robert Mackey
No relevant relationships to disclose
David Goldstein
Consultant or Advisory Role - Celgene (U)
Research Funding - Celgene